Social determinant screening not enough to capture patients at risk of utility shut-off

BOSTON- Researchers at Boston Medical Center have found that only a fraction of patients at risk of having their utilities shut off were identified through social determinants of health (SDOH) screening. Published in The Journal of Ambulatory Care Management, the research showed that among the patients who received a utility protection letter in 2018, 70…

Details

Recent research points the way toward a practical nutraceutical strategy for coping with RNA virus infections including influenza and coronavirus

Philadelphia, February 24, 2020 – In a compelling article in Progress in Cardiovascular Diseases, published by Elsevier, Mark McCarty of the Catalytic Longevity Foundation, San Diego, CA, USA, and James DiNicolantonio, PharmD, a cardiovascular research scientist at Saint Luke’s Mid America Heart Institute, Kansas City, MO, USA, propose that certain nutraceuticals may help provide relief…

Details

ACR releases reproductive health guideline for patients with rheumatic diseases

ATLANTA – Today, the American College of Rheumatology (ACR) published the 2020 Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases. This is the first, evidence-based, clinical practice guideline related to the management of reproductive health issues for all patients with rheumatic diseases. With 131 recommendations, the guideline offers general precepts that…

Details

Too much of a good thing may lead to too much of a liver as well

All life is challenged by oxidants — reactive molecules or compounds that remove electrons from other molecules — often with adverse effect, commonly referred to as oxidative stress. Consequently, all organisms have evolved specialized antioxidant defenses. In humans and other multicellular animals, that defense depends upon a protein called NRF2 and its inhibitor, KEAP1. In…

Details

‘CRISPR: A Screener’s Guide’ headlines the March edition of SLAS Discovery

Oak Brook, IL – The March edition of SLAS Discovery features the cover article, “CRISPR: A Screener’s Guide,” by Carlos le Sage, Ph.D., Steffen Lawo, Ph.D., and Benedict C.S. Cross, Ph.D., (Horizon Discovery, United Kingdom). In their review, the authors discuss how CRISPR-Cas9 systems are being used widely throughout the drug discovery process and the…

Details